Pemupukan Nitrogen, Fosfor, Dan Kalium Pada Tanaman Akar Wangi

The optimum dosage of N, P, and K fertilizer has not been knownyet and it USAge was still varied. The research aim is to obtain an optimalcomposition of N, P, and K fertilizer that could increase productivity ofvetiver crop. The researsch has been conducted in Sukakarya Village,Garut, from January 2009 to December 2010. The research was arrangedin randomized block design, with 3 replications and N, P, and K fertilizercombination treatments i.e.: (1) Control; (2) 100 kg SP-36 + 75 kg KCl;(3) 100 kg ZA + 75 kg KCl; (4) 100 kg ZA + 50 kg SP-36 + 75 kg KCl;(5) 100 kg ZA + 100 kg SP-36 + 75 kg KCl; (6) 100 kg ZA + 100 kg SP-36 + 150 kg KCl; (7) 100 kg ZA + 100 kg SP-36; (8) 200 kg ZA + 100 kgSP-36 + 75 kg KCl; (9) 200 kg ZA + 100 kg SP-36 + 150 kg KCl.Harvesting was done at 12, 14 and 16 months after planting (MAP). Theresult showed that the dose of 100 kg ZA + 75 kg KCl produced vetiver oil52,59 and 67,78 kg/ha (12 and 14 MAP). Meanwhile the dose of 200 kgZA + 100 kg SP-36 + 75 kg KCl produced 67,76 kg/ha (16 MAP),respectively. vetiverol content were more than 50%

Improved Anticancer Effect of Magnetite Nanocomposite Formulation of GALLIC Acid (Fe₃O₄-PEG-GA) Against Lung, Breast and Colon Cancer Cells

Lung cancer, breast cancer and colorectal cancer are the most prevalent fatal types of cancers globally. Gallic acid (3,4,5-trihydroxybenzoic acid) is a bioactive compound found in plants and foods, such as white tea, witch hazel and it has been reported to possess anticancer, antioxidant and anti-inflammatory properties. In this study we have redesigned our previously reported anticancer nanocomposite formulation with improved drug loading based on iron oxide magnetite nanoparticles coated with polyethylene glycol and loaded with anticancer drug gallic acid (Fe₃O₄-PEG-GA). The in vitro release profile and percentage drug loading were found to be better than our previously reported formulation. The anticancer activity of pure gallic acid (GA), empty carrier (Fe₃O₄-PEG) nanocarrier and of anticancer nanocomposite (Fe₃O₄-PEG-GA) were screened against human lung cancer cells (A549), human breast cancer cells (MCF-7), human colon cancer cells (HT-29) and normal fibroblast cells (3T3) after incubation of 24, 48 and 72 h using (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) MTT assay. The designed formulation (Fe₃O₄-PEG-GA) showed better anticancer activity than free gallic acid (GA). The results of the in vitro studies are highly encouraging to conduct the in vivo studies

pp-Process simulations with a modified reaction library

We have performed $p$-process simulations with the most recent stellar $(n,\gamma)$ cross sections from the "Karlsruhe Astrophysical Database of Nucleosynthesis in Stars" project (version v0.2, http://nuclear-astrophysics.fzk.de/kadonis). The simulations were carried out with a parametrized supernova type II shock front model (``$\gamma$ process'') of a 25 solar mass star and compared to recently published results. A decrease in the normalized overproduction factor could be attributed to lower cross sections of a significant fraction of seed nuclei located in the Bi and Pb region around the $N$=126 shell closure.Comment: 5 pages, 1 figure Proceedings "Nuclear Physics in Astrophysics NPA-III", Dresden/Germany (2007

Atypical propylthiouracil-induced ANCA-positive vasculitis: report of a case with unusual clinical and histopathologic findings

The side effects of propylthiouracil, including cytopenia and vasculitis, are well established.  We present an interesting case in which cytopenia and cutaneous vasculopathy occurred concomitantly in a critically ill patient.  The patient was initially treated for suspected infection until dermatologic and rheumatologic workup revealed ANCA-positivity and vasculopathy on histopathology, most consistent with an atypical presentation of ANCA-positive vasculitis.  Upon initiation of immunosuppressive therapy, the patient’s condition rapidly improved emphasizing the importance of early recognition of this condition

HST Observations of Heavy Elements in Metal-Poor Galactic Halo Stars

We present new abundance determinations of neutron-capture elements Ge, Zr, Os, Ir, and Pt in a sample of 11 metal-poor (-3.1 <= [Fe/H] <= -1.6) Galactic halo giant stars, based on Hubble Space Telescope UV and Keck I optical high-resolution spectroscopy. The stellar sample is dominated by r-process-rich stars such as the well-studied CS 22892-052 and bd+173248, but also includes the r-process-poor, bright giant HD 122563. Our results demonstrate that abundances of the 3rd r-process peak elements Os, Ir and Pt in these metal-poor halo stars are very well-correlated among themselves, and with the abundances of the canonical r-process element Eu (determined in other studies), thus arguing for a common origin or site for r-process nucleosynthesis of heavier (Z>56) elements. However, the large (and correlated) scatters of [Eu,Os,Ir,Pt/Fe] suggests that the heaviest neutron-capture r-process elements are not formed in all supernovae. In contrast, the Ge abundances of all program stars track their Fe abundances, very well. An explosive process on iron-peak nuclei (e.g., the alpha-rich freeze-out in supernovae), rather than neutron capture, appears to have been the dominant synthesis mechanism for this element at low metallicities -- Ge abundances seem completely uncorrelated with Eu.Comment: 35 pages, 5 tables, 7 figures; To appear in the Astrophysical Journa

Learning object relationships which determine the outcome of actions

Peer reviewedPublisher PD

Beta decay of 115-In to the first excited level of 115-Sn: Potential outcome for neutrino mass

Recent observation of beta decay of 115-In to the first excited level of 115-Sn with an extremely low Q_beta value (Q_beta ~ 1 keV) could be used to set a limit on neutrino mass. To give restriction potentially competitive with those extracted from experiments with 3-H (~2 eV) and 187-Re (~15 eV), atomic mass difference between 115-In and 115-Sn and energy of the first 115-Sn level should be remeasured with higher accuracy (possibly of the order of ~1 eV).Comment: 9 pages, 3 figures; talk at the NANP'05 Conferenc

Predicting prostate cancer treatment choices: The role of numeracy, time discounting, and risk attitudes

Prostate cancer is the most common cancer among males in the United States and there is lack of consensus as to whether active surveillance (AS) or radical prostatectomy (RP) is the best course of treatment. In this study we examined the role of three overlooked determinants of decision making about prostate cancer treatment in a hypothetical experiment—numeracy, time discounting, and risk taking in 279 men over age 50 without a prior prostate cancer diagnosis. Results showed that AS was the most frequently chosen option. Furthermore, numeracy and time discounting significantly predicted participants’ preference for AS, whereas a propensity to take risks was associated with a preference for RP. Such insights into the factors that affects cancer treatment preferences may improve tailored decision aids and help physicians be better poised to engage in shared decision-making to improve both patient-reported and clinical outcomes